| Literature DB >> 27812517 |
Jimin Kang1, Joon Seong Park2, Dong Sup Yoon2, Woo Jeong Kim3, Hae-Yun Chung4, Song Mi Lee5, Namsoo Chang1.
Abstract
The adequate dietary intake is important to maintain the nutritional status of the patients after pancreatic cancer surgery. This prospective study was designed to investigate the dietary intake and the nutritional status of the patients who had pancreatic cancer surgery. Thirty-one patients (15 men, 16 women) were enrolled and measured body weight, body mass index (BMI), nutritional risk index (NRI), and Malnutrition Universal Screening Tool (MUST). Actual oral intake with nutritional impact symptoms recorded on the clinical research foam at every meal and medical information were collected from electronic medical charts. The rates of malnutrition at admission were 45.1% (14/31) and 28.9% (9/31) by NRI and MUST method, respectively, but those were increased to 87% (27/31) and 86.6% (26/31) after operation on discharge. The median values of daily intake of energy, carbohydrates, fat, and protein were 588.1 kcal, 96.0 g, 11.8 g, and 27.0 g, respectively. Most patients (n = 20, 64.5%) experienced two or more symptoms such as anorexia, abdominal bloating and early satiety. There were negative correlations between C-reactive protein (CRP) levels and the intake of total energy, protein, fat, and zinc. The rates of malnutrition were increased sharply after surgery and the dietary intake also influenced the inflammatory indicators. The results suggested that need of considering special therapeutic diets for the patients who received pancreatic surgery.Entities:
Keywords: Dietary intake; Nutrition; Pancreatic cancer surgery
Year: 2016 PMID: 27812517 PMCID: PMC5093225 DOI: 10.7762/cnr.2016.5.4.279
Source DB: PubMed Journal: Clin Nutr Res ISSN: 2287-3732
Figure 1Flow sheet of the enrollment.
M, male; F, female; LOS, length of hospital
Figure 2Scheduled diet orders for the subjects after pancreatic surgery.
NPO, nothing by mouth.
General characteristics of the study subjects*
| Variables | Total (n = 31) | |
|---|---|---|
| Sex | ||
| Men | 15 (48.3)* | |
| Women | 16 (51.6) | |
| Age, yr | 60 (31–81) | |
| 30–49 | 6 (19.4) | |
| 50–69 | 20 (64.5) | |
| 70–89 | 5 (16.2) | |
| Medical history | ||
| Hypertension | 7 (19.4) | |
| Diabetes | 6 (16.7) | |
| Cancer | 3 (8.3) | |
| Others | 5 (13.9) | |
| None | 15 (41.7) | |
| Operation | ||
| PPPD | 25 (80.6) | |
| DP | 6 (19.4) | |
| Disease | ||
| Benign | 8 (25.8) | |
| Malignant | 23 (74.2) | |
| Length of hospital, day | 12 (7–31) | |
| Fasting duration, day | 2 (1–9) | |
| Enteral feeding duration, day | 3 (0–12) | |
| Oral intake duration, day | 7 (4–18) | |
| Liquid diet | 1 (1–5) | |
| Soft diet | 6 (3–13) | |
PPPD, pylorus preserving pancreaticoduodenectomy; DP, distal pancreatectomy.
*Values are presented as median (min–max) or number (%).
Comparison of nutritional status among the subjects before and after surgery*
| Total (n = 31) | Preoperative | After operation on discharge | p value† | |
|---|---|---|---|---|
| Weight, kg | 60.7 (40.1–82.5)* | 60.1 (39.0–79.0) | < 0.001 | |
| BMI, kg/m2 | 22.9 (15.9–30.3) | 22.0 (15.3–29.3) | < 0.001 | |
| NRI | n = 31 | n = 31 | 0.002‡ | |
| No nutritional risk | 17 (54.8)* | 4 (12.9) | ||
| Mild risk | 4 (12.9) | 1 (3.2) | ||
| Moderate/Severe risk | 10 (32.2) | 26 (83.8) | ||
| MUST | n = 31 | n = 30 | < 0.001 | |
| Low risk | 22 (70.9) | 4 (13.3) | ||
| Medium risk | 2 (6.4) | 3 (10.0) | ||
| High risk | 7 (22.5) | 23 (76.6) | ||
BMI, body mass index; NRI, nutritional risk index; MUST, Malnutrition Universal Screening Tool.
*Values are presented as median (min–max) or number (%); †From Wilcoxon signed-ranks test for continuous variables; ‡From McNemar’s test for continuous variables.
Comparison of clinical data between before and after surgery (n = 31)*
| Variables | Preoperative | Postoperative | p value† |
|---|---|---|---|
| Hb, g/dL | 12.3 (9.5–14.7)* | 10.1 (8.2–12.6) | < 0.001 |
| TP, g/dL | 6.8 (5.5–8.2) | 5.8 (4.7–6.9) | < 0.001 |
| Alb, g/dL | 4.0 (3.1–4.6) | 3.4 (2.7–4.5) | 0.001 |
| Chol, mg/dL | 165.0 (62.0–447.0) | 115.0 (48.0–204.0) | < 0.001 |
| CRP, mg/L | 1.1 (0.1–105.3) | 7.3 (0.6–43.6) | 0.001 |
| WBC, 103/µL | 6.1 (4.1–13.2) | 7.4 (2.6–10.6) | 0.570 |
| Neutrophil, 103/µL | 3.5 (1.5–11.0) | 4.9 (1.0–7.6) | 0.399 |
| Lymphocyte, 103/µL | 1.6 (0.8–2.7) | 1.4 (0.4–3.9) | 0.213 |
Hb, hemoglobin; TP, total protein; Alb, albumin; Chol, cholesterol; CRP, C-reactive protein; WBC, white blood cell.
*Values are presented as median (min–max); †From Wilcoxon signed-ranks test for continuous variables.
Dietary nutrient intakes of the subjects by BMI after surgery*
| Variables | Total (n = 31) | BMI < 23 (n = 18) | BMI ≥ 23 (n = 13) | p value† |
|---|---|---|---|---|
| Energy, kcal | 588.1 (119.5–1,204.8)* | 588.3 (187.2–1,204.8) | 553.5 (119.5–816.3) | 0.173 |
| Carbohydrate, g | 96.0 (15.5–247.2) | 96.5 (36.6–247.2) | 96.0 (15.5–151.4) | 0.230 |
| Fat, g | 11.8 (1.4–29.0) | 14.4 (1.4–29.0) | 10.8 (3.3–25.7) | 0.357 |
| Protein, g | 27.0 (6.6–59.2) | 27.6 (7.0–59.2) | 23.5 (6.6–46.4) | 0.548 |
| Fiber, g | 7.2 (1.2–14.6) | 8.3 (1.9–14.6) | 6.6 (1.2–13.2) | 0.317 |
| Vitamin A, µg RE | 373.1 (58.5–857.6) | 446.7 (58.5–857.6) | 312.4 (63.9–831.1) | 0.548 |
| Vitamin D, µg | 1.3 (0.0–7.5) | 1.4 (0.0–7.5) | 1.2 (0.0–5.3) | 0.904 |
| Vitamin E, mg | 5.6 (0.7–16.7) | 5.3 (0.7–13.1) | 5.6 (0.8–16.7) | 0.689 |
| Vitamin K, µg | 98.9 (4.6–260.0) | 109.7 (4.6–260.0) | 71.4 (9.1–257.5) | 0.575 |
| Vitamin C, mg | 46.6 (4.8–124.7) | 54.5 (14.6–104.7) | 41.8 (4.8–124.7) | 0.378 |
| Vitamin B1, mg | 0.4 (0.0–0.8) | 0.4 (0.1–0.8) | 0.3 (0.0–0.7) | 0.401 |
| Vitamin B2, mg | 0.3 (0.0–0.9) | 0.3 (0.0–0.9) | 0.4 (0.0–0.9) | 0.968 |
| Niacin, mg | 5.4 (1.2–14.7) | 5.6 (1.6–14.7) | 4.9 (1.2–9.1) | 0.548 |
| Vitamin B6, mg | 0.5 (0.1–1.2) | 0.6 (0.1–1.2) | 0.5 (0.1–0.9) | 0.603 |
| Folate, µg | 203.3 (41.0–396.7) | 228.9 (68.8–396.7) | 176.0 (41.0–359.8) | 0.357 |
| Vitamin B12, µg | 1.8 (0.1–7.3) | 1.7 (0.1–7.3) | 2.4 (0.8–4.5) | 0.317 |
| Calcium, mg | 228.8 (31.0–593.4) | 233.9 (42.1–593.4) | 227.4 (31.0–478.7) | 0.936 |
| Phosphorus, mg | 428.4 (110.1–925.1) | 430.5 (110.1–925.1) | 365.1 (115.0–631.9) | 0.496 |
| Sodium, mg | 3,611.3 (440.2–7,210.3) | 3,780.6 (760.8–7,148.4) | 2,373.6 (440.2–7,210.3) | 0.280 |
| Potassium, mg | 1,106.5 (157.0–2,435.1) | 1,098.3 (293.0–2,435.1) | 1,113.2 (157.0–2,001.2) | 0.719 |
| Iron, mg | 5.0 (1.2–14.1) | 5.2 (1.7–14.1) | 4.3 (1.2–9.6) | 0.401 |
| Zinc, mg | 3.6 (0.6–7.2) | 3.7 (1.0–7.2) | 3.4 (0.6–5.5) | 0.423 |
| Chol, mg | 53.9 (2.2–201.6) | 83.9 (4.5–201.6) | 45.9 (2.2–177.1) | 0.522 |
BMI, body mass index; Chol, cholesterol.
*Values are presented as median (min–max); †From Mann-Whitney test for continuous variables.
Daily consumption of total calorie and protein through parenteral and oral intakes among study subjects*
| Oral diet day | Energy, kcal | Protein, g | ||||
|---|---|---|---|---|---|---|
| Oral intake | Parenteral intake | Total | Oral intake | Parenteral intake | Total | |
| 1 | 554.0 | 1,082.2 | 1,636.2 | 13.9 | 48.7 | 62.6 |
| 2 | 610.1 | 825.5 | 1,435.6 | 21.7 | 38.6 | 60.3 |
| 3 | 632.2 | 300.6 | 932.8 | 30.5 | 16.7 | 47.2 |
| 4 | 663.8 | 28.4 | 692.2 | 34.2 | 2.7 | 36.9 |
| 5 | 719.0 | 28.4 | 747.4 | 38.3 | 4.7 | 43.0 |
| 6 | 699.6 | 15.7 | 715.3 | 34.6 | 8.7 | 43.3 |
| 7 | 596.8 | 19.5 | 616.3 | 35.6 | 2.8 | 38.4 |
*Values are median.
Nutritional impact symptoms of study subjects after operation*
| Variables | Total (n = 31) | |
|---|---|---|
| No. of nutritional impact symptoms | ||
| 0–1 | 11 (35.4)* | |
| 2–4 | 16 (51.6) | |
| ≥ 5 | 4 (12.9) | |
| Nutritional impact symptoms | ||
| Loss of appetite | 12 (38.7) | |
| Abdominal distension | 11 (35.4) | |
| Early satiety | 10 (32.2) | |
| Abdomen pain | 8 (25.8) | |
| Nausea | 7 (22.5) | |
| Diarrhea/loose stool | 5 (16.1) | |
| Vomiting | 4 (12.9) | |
| Gas | 3 (9.6) | |
| Indigestion | 2 (6.4) | |
*Values are presented as number (%).
Correlation coefficients of dietary intake and nutritional statement (n = 31)
| Variables | Weight change amount | BMI change amount | Alb change amount | CRP change amount | Hb change amount | TP change amount | Chol change amount | WBC change amount | Neutrophil change amount | Lymphocyte change amount |
|---|---|---|---|---|---|---|---|---|---|---|
| Energy, kcal | −0.283 | −0.258 | 0.139 | −0.289 | 0.030 | 0.067 | 0.052 | −0.481* | −0.454* | −0.275 |
| Protein, g | −0.184 | −0.161 | 0.159 | −0.384* | 0.083 | 0.019 | 0.030 | −0.500* | −0.531* | −0.183 |
| Carbohydrate, g | −0.298 | −0.269 | 0.176 | −0.134 | 0.046 | 0.196 | 0.110 | −0.333* | −0.266 | −0.311* |
| Lipid, mL | −0.248 | −0.230 | 0.098 | −0.332* | 0.028 | −0.034 | 0.011 | −0.540* | −0.539* | −0.256 |
| Sodium, mg | −0.258 | −0.250 | 0.135 | −0.193 | 0.035 | 0.002 | −0.316* | −0.269 | −0.360* | −0.216 |
| Potassium, mg | −0.087 | −0.070 | 0.073 | −0.023 | −0.152 | 0.004 | −0.140 | −0.196 | −0.261 | −0.185 |
| Calcium, mEq | 0.038 | 0.048 | −0.023 | −0.140 | −0.150 | −0.031 | −0.177 | −0.400* | −0.460* | −0.192 |
| Zinc, mg | −0.248 | −0.218 | 0.102 | −0.335* | −0.029 | −0.046 | −0.115 | −0.545* | −0.560* | −0.274 |
From Spearman correlation for continuous variables; Variable change (%) = Data after operation/Data before operation × 100.
BMI, body mass index; Alb, albumin; CRP, C-reactive protein; Hb, hemoglobin; TP, total protein; Chol, cholesterol; WBC, white blood cell.
*p < 0.05.
Correlation coefficients of dietary food group intakes and number of nutrition impact symptoms (n = 31)
| Food group, g | Total (n = 31) |
|---|---|
| Cereal and cereal products | −0.375* |
| Potatoes and starch products | 0.195 |
| Sugar and sugar products | −0.329* |
| Beans and bean products | 0.014 |
| Nuts and seeds products | −0.057 |
| Vegetables | −0.111 |
| Mushrooms | 0.096 |
| Fruits | −0.129 |
| Meat and meat products | 0.042 |
| Eggs and egg products | 0.113 |
| Fishes and shellfish | 0.075 |
| Seaweeds | 0.220 |
| Milk and milk products | 0.099 |
| Oil and fat | 0.060 |
*p < 0.05.